VC Fund
🇫🇷 Lauxera Growth II
Lauxera Capital Partners SAS · France
Fund size
EUR 520M
Stages
Growth
Focus
Health & Bio
EIF sector
Life Science
About Lauxera Growth II
Lauxera Growth II is a healthtech growth-equity fund managed by Lauxera Capital Partners, a firm with offices in Paris and San Francisco. It closed at EUR 520 million in 2026 and writes EUR 20-50 million tickets into 12 to 15 commercial-stage healthtech companies across medical devices, digital health, diagnostics and life-science tools, with a focus on US and global expansion. Early investments include Germany's Acandis and Sweden's Antaros Medical.
EUACC IntelligenceFree preview
EUACC Intelligence
Ask about Lauxera Growth II
Get instant answers about Lauxera Growth II and how it fits your raise.